Eculizumab in the treatment of atypical hemolytic uremic syndrome in an infant leads to cessation of peritoneal dialysis and improvement of severe hypertension
Crossref DOI link: https://doi.org/10.1007/s00467-014-2975-4
Published Online: 2014-10-16
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ohta, Toshiyuki
Urayama, Kohtaro
Tada, Yoshihiro
Furue, Takeki
Imai, Sayaka
Matsubara, Keita
Ono, Hiroaki
Sakano, Takashi
Jinno, Kazuhiko
Yoshida, Yoko
Miyata, Toshiyuki
Fujimura, Yoshihiro
Text and Data Mining valid from 2014-10-16